GlassScriptPhysician profile
Jon B Scott
NPI 1861462277
$1,779.67
in general payments reported to CMS, 2019-2025
13 companies · $279 in 2025
The $279 reported for 2025 was more than what a typical Optometrist provider received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $162 · 2020: $134 · 2021: $575 · 2022: $200 · 2023: $241 · 2024: $189 · 2025: $279.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $709.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $708.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $899.90 | 2020-2025 | Clareon, Dailies Total1, Precision7 |
| Bausch & Lomb Americas INC. | $237.93 | 2023-2025 | Infuse, Vyzulta, Miebo |
| Sun Pharmaceutical Industries INC. | $194.60 | 2019-2021 | |
| Glaukos Corporation | $139.85 | 2022 | |
| Dompe US, INC. | $87.32 | 2020-2025 | Oxervate |
| Tarsus Pharmaceuticals, INC. | $73.57 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $37.32 | 2019-2020 | |
| Abbvie INC. | $25.60 | 2024 | |
| Novartis Pharmaceuticals Corporation | $21.82 | 2020 | |
| Johnson & Johnson Vision Care, INC. | $17.52 | 2024 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $14.62 | 2020 | |
| Kala Pharmaceuticals, INC. | $12.38 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jon Scott listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.